Evolution of the Average Target: AXT, Inc.

Evolution of the Target Price: AXT, Inc.

Changes in Analyst Recommendations: AXT, Inc.

1717a59bf5d611f.DsFnzY6qWFux0d9fRa5TaDH1YfbygtWjK8tP22s-FcY.PaRTnt3OIQrStJIrF_kqP0asCbPC05bpbqB4vhh8ILQ3iQOo1MxgHMno5w~30faba1abc9582d7acd198faf166540b
05-01 Wedbush Adjusts Price Target on AXT to $93 From $80, Maintains Outperform Rating MT
05-01 B. Riley Adjusts Price Target on AXT to $73 From $72, Maintains Neutral Rating MT
04-29 Wedbush Boosts Price Target on AXT Inc. to $80 From $28, Keeps Outperform Rating MT
04-22 B. Riley Boosts Price Target on AXT Inc. to $72 From $21, Keeps Neutral Rating MT
02-20 Wedbush Boosts Price Target on AXT Inc. to $28 From $8.50, Keeps Outperform Rating MT
01-20 Needham Downgrades AXT to Hold From Buy MT
01-09 B. Riley Downgrades AXT to Neutral From Buy, Adjusts Price Target to $18 From $9 MT
29/10/25 Wedbush Raises Price Target on AXT Inc. to $7 From $4.10, Keeps Outperform Rating MT
10/07/25 B. Riley Adjusts Price Target on AXT to $4.30 From $4.50, Maintains Buy Rating MT
21/02/25 Wedbush Adjusts AXT Price Target to $4.50 From $5.50, Maintains Outperform Rating MT
05/04/24 B. Riley Ups Price Target on AXT to $5.50 From $3.80, Maintains Buy Rating MT
23/02/24 Craig-Hallum Upgrades AXT to Buy From Hold, Adjusts Price Target to $3.75 From $2.25 MT
23/02/24 B. Riley Upgrades AXT to Buy From Neutral, Believes AI Could Drive Multiple Expansion; Adjusts PT to $3.80 From $2.40 MT
03/11/23 B. Riley Trims AXT's PT to $2.40 From $3.30 After Below-Consensus Q3 Results, Q4 Outlook; Keeps Neutral Rating MT
04/08/23 B. Riley Trims AXT's Price Target to $3.30 From $3.70, Keeps Neutral Rating MT
04/08/23 Wedbush Lowers AXT's Price Target to $6 From $10, Says Near-Term Outlook Remains Difficult, Keeps Outperform Rating MT
16/06/23 Needham Cuts Price Target on AXT to $5 From $8, Maintains Buy Rating MT
28/04/23 Needham Adjusts Price Target on AXT to $5 From $8, Maintains Buy Rating MT
28/04/23 B. Riley Lowers AXT's PT to $3.70 From $5 After Mixed Q1 Print, Notes 'Tepid' Outlook as Timing of Recovery Remains Uncertain; Keeps Neutral Rating MT
17/02/23 Needham Adjusts Price Target on AXT to $8 From $6, Maintains Buy Rating MT
17/02/23 B. Riley Trims AXT's Price Target to $5 From $5.50, Maintains Neutral Rating MT
17/02/23 Wedbush Cuts Price Target on AXT to $10 From $13, Cites Softer-Than-Expected Sales, 'Poor' Revenue Outlook; Outperform Rating Kept MT
28/10/22 Needham Trims Price Target on AXT to $6 From $6, Keeps Buy Rating MT
28/10/22 B. Riley Lowers AXT's Price Target to $5.50 From $6.50, Notes 'Soft' Q4 Outlook; Keeps Neutral Rating MT
06/10/22 BWS Financial Adjusts AXT's Price Target to $12 from $20, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+54.28%
+48.74%
+17.35%
+30.57%
+49.85%
+46.75%
-6.3%
-10.36%
-8.85%
-3.41%
Average +21.86%
Weighted average by Cap. +32.30%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
62.55USD
Average target price
96.50USD
Spread / Average Target
+54.28%
High Price Target
125.00USD
Spread / Highest target
+99.84%
Low Price Target
73.00USD
Spread / Lowest Target
+16.71%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wedbush
B. Riley
Needham & Co.
Craig-Hallum
BWS Financial
Northland Securities
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
62.55USD
Average target price
96.50USD
Spread / Average Target
+54.28%

Quarterly revenue - Rate of surprise